Cite
HARVARD Citation
Shaulov, A. et al. (n.d.). Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. American journal of hematology. 92 (2), pp. 131-135. [Online].